When was Laminate Medical founded?

Laminate Medical was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Where is Laminate Medical located?

Laminate Medical is headquartered in Rehovot, Israel.

Who is the current CEO of Laminate Medical?

Tammy Gilon of Laminate Medical.

How many employees does Laminate Medical have?

As of May 31, 2026, the latest employee count at Laminate Medical is 36.

Is Laminate Medical a funded company?

Laminate Medical is a funded company, having raised a total of $20M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 06, 2014.

When was the latest funding round of Laminate Medical?

Laminate Medical's latest funding was a $***** Series C round on Oct 24, 2019, with participation from 1 investor.

Where does Laminate Medical rank among its competitors?

Laminate Medical ranks 3rd amongst 115 active competitors, of which 46 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was ivWatch, which secured $26.9M in Jan, 2024.

Who are the top competitors of Laminate Medical?

Laminate Medical's top competitors include TISSIUM, Vivasure Medical and EKOS Corporation. Among them, ivWatch secured the most recent funding round in January, 2024.

Laminate Medical - 2026 Company Profile, Team, Funding & Competitors

Laminate Medical is a series C company based in Rehovot (Israel), founded in 2012 by Eyal Orion and Tammy Gilon. It operates as a Device to prevent AV Fistula failure by promoting their maturation and patency. Laminate Medical has raised $20M in funding from investors like Rad, Valiance Asset Management and Haisco Pharmaceutical Group. The company has 115 active competitors, including 46 funded and 29 that have exited. Its top competitors include companies like TISSIUM, Vivasure Medical and EKOS Corporation.

Company Details

Laminate medical produces VasQ, a device designed to improve maturation and patency rates of AV fistulas. It provides external support thereby addressing the root causes of fistula failure. Failure is often due to clotting and thrombosis of the fistula which is caused by turbulent flow patterns around the anastomosis region, which VasQ prevents. Early failure occurs in over 40% of fistulas created using conventional techniques.The VasQ is not available in the US

Website: www.laminatemedical.com/
Social
Email ID: *****@laminatemedical.com

Key Metrics

Founded Year

2012

Location

Rehovot, Israel

Stage

Series C

Total Funding

$20M in 6 rounds

Latest Funding Round

Series C, Oct 24, 2019, $*****

Investors

Rad & 26 more

Ranked

3^rd among 115 active competitors

Employee Count

36 as on May 31, 2026

Investment & Acquisitions

Aspect Imaging

Similar Companies

TISSIUM & 158 more

View Laminate Medical's full profile

Laminate Medical has raised a total funding of $20M over 6 rounds. Its first funding round was on Apr 06, 2014. Its latest funding round was a Series C round on Oct 24, 2019 for $*****. 1 investor participated in its latest round. Laminate Medical has 17 institutional investors and 10 angel investors.

Here is the list of recent funding rounds of Laminate Medical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 24, 2019	2724209	Series C	4971350	2618261	1497789	2734997
Jan 31, 2019	3570887	Series C	9857358	4983414	1219498	ADIP & 12 more
Feb 07, 2017	6095502	Series B	9808613	6405177	Haisco Pharmaceutical Group	1558008

Access funding benchmarks and valuations. Sign up today!

View details of Laminate Medical's funding rounds and investors

The founders of Laminate Medical are Eyal Orion and Tammy Gilon.

Here are the details of Laminate Medical's key team members:

Eyal Orion: Co-Founder & Board Member of Laminate Medical.
Tammy Gilon: Co-Founder & CEO of Laminate Medical.
Contact Info: 1 email address

View details of Laminate Medical's Founder profiles and Board Members

Laminate Medical's employee count trend

Laminate Medical has 36 employees as of May 26. Here is Laminate Medical's employee count trend over the years:

Employee count trend for Laminate Medical

Uncover Laminate Medical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Laminate Medical include TISSIUM, Vivasure Medical and EKOS Corporation. Here is the list of Top 10 competitors of Laminate Medical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TISSIUM 2013, Paris (France), Series D	Developer of vascular sealant for open vascular surgery	$156M	Cathay Capital, Sofinnova Partners & 15 others	65/100
2nd	Vivasure Medical 2009, Galway (Ireland), Acquired	Developer of polymer implants and delivery systems	$92.1M	Fountain Healthcare Partners, Ascent Biomedical Ventures ... & 12 others	61/100
3rd	Laminate Medical 2012, Rehovot (Israel), Series C	Device to prevent AV Fistula failure by promoting their maturation and patency	$20M	Kreos Capital, AA Sons & 25 others	52/100
4th	EKOS Corporation 1995, Bothell (United States), Acquired	Developer of a device for thrombolysis to treat pulmonary embolism	$58.8M	Hercules Capital, Mitsui & 17 others	52/100
5th	ivWatch 2010, Williamsburg (United States), Series E	Detecting Intravenous infiltration	$90.1M	757 Angels	51/100
6th	AccessClosure 2002, Mountain View (United States), Acquired	Vascular closure device	$18.7M	Industry Ventures, HealthCor Partners & 5 others	50/100
7th	Cardival Medical 2002, Santa Clara (United States), Acquired	Developer of a device for vascular access management	$169M	LKCM, Western Technology Investment & 12 others	49/100
8th	Phraxis 2008, St. Paul (Canada), Series B	Vascular access device for hemodialysis	$14.4M	-	49/100
9th	SINOMED 2007, Tianjin (China), Funding Raised	Provider of coronary stent and interventional devices	-	CoStone Capital, Decheng Capital & 5 others	47/100
10th	Aziyo Biologics 2015, Silver Spring (United States), Public	Developer of regenerative medicine products for various applications	$49.6M	Deerfield, HighCape Capital & 2 others	47/100